Call for Abstract

31st World Congress on Neurology & Neuroscience, will be organized around the theme “Current Trends in Neurology & Neurodisorders Research”

World Neurology 2019 is comprised of 31 tracks and 401 sessions designed to offer comprehensive sessions that address current issues in World Neurology 2019.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Neuroethology
  • Track 1-2Affective neuroscience
  • Track 1-3Behavioral neuroscience
  • Track 1-4Cellular neuroscience
  • Track 1-5Clinical neuroscience
  • Track 1-6Cognitive neuroscience
  • Track 1-7Cultural neuroscience
  • Track 1-8Cultural neuroscience
  • Track 1-9Developmental neuroscience
  • Track 1-10Evolutionary Neuroscience
  • Track 1-11Molecular Neuroscience
  • Track 1-12Neural Engineering
  • Track 1-13Neuroanatomy
  • Track 1-14Neurochemistry
  • Track 1-15Systems neuroscience
  • Track 1-16Neurogastronomy
  • Track 1-17Neurogenetics
  • Track 1-18Neuroimaging
  • Track 1-19Neuroimmunology
  • Track 1-20Neuroinformatics
  • Track 1-21Neurolinguistics
  • Track 1-22Neurolinguistics
  • Track 1-23Neurophysics
  • Track 1-24Neurophysiology
  • Track 1-25Neuropsychology
  • Track 1-26Paleoneurobiology
  • Track 1-27Social neuroscience
  • Track 2-1Cerebrovascular disease
  • Track 2-2Cognitive impairment
  • Track 2-3Dementias
  • Track 2-4Pseudobulbar palsy
  • Track 2-5Dysarthrias
  • Track 2-6Perseverative behavior
  • Track 2-7Syphilis
  • Track 2-8Cerebrovascular disease
  • Track 2-9Hypercholesterolemia
  • Track 2-10Erythrocyte sedimentation rate
  • Track 2-11Atheroma

The study of Neuroscience mainly focuses on the nervous system, which affects all aspects of the body and brain. Neuroscientists study the evolutionary, cellular, behavioral, functional, computational, molecular, cellular each and every medical aspects of the nervous system.

  • Track 3-1Neuropsychology
  • Track 3-2Molecular & Cellular neuroscience
  • Track 3-3Cognitive & Behavioral neuroscience
  • Track 3-4Nervous system
  • Track 3-5Spinal cord
  • Track 3-6Neurons & Axons
  • Track 3-7Neuronal Migration
  • Track 3-8Neuroendocrinology & Psychoneuroimmunology
  • Track 3-9Neural circuitry
  • Track 3-10Pain Medicine
  • Track 3-11Clinical Neurophysiology
  • Track 3-12Neuropathology
  • Track 3-13Integrative Neuroscience
  • Track 3-14Computational neuroscience
  • Track 3-15Chronic neurodegenerative disease
  • Track 4-1Cell death
  • Track 4-2Transient Ischemic attack
  • Track 4-3Medical imaging
  • Track 4-4Thrombotic stroke
  • Track 4-5Embolic stroke
  • Track 4-6Cerebral hypoperfusion
  • Track 4-7Venous thrombosis
  • Track 4-8Intracerebral hemorrhage
  • Track 4-9Silent stroke
  • Track 4-10Brain ischemia
  • Track 4-11Cerebral infarction
  • Track 4-12Intracerebral hemorrhage
  • Track 4-13Subarachnoid hemorrhage
  • Track 4-14Head injury
  • Track 4-15Cerebral cortex
  • Track 4-16Cerebral cortex
  • Track 5-1Epileptic seizures
  • Track 5-2Epileptogenesis
  • Track 5-3Neurostimulation
  • Track 5-4Obsessive compulsive disorder
  • Track 5-5Down syndrome
  • Track 5-6Angelman syndrome
  • Track 5-7Cerebral cavernous malformations
  • Track 5-8Arteriovenous malformations
  • Track 5-9Coeliac disease
  • Track 5-10Cerebral malaria
  • Track 5-11Toxoplasmosis
  • Track 5-12Cerebral palsy
  • Track 5-13Spastic quadriplegia
  • Track 5-14Spastic hemiplegia
  • Track 6-1Degenerative disorder
  • Track 6-2Antiparkinson medication levodopa
  • Track 6-3Synucleinopathy
  • Track 6-4Cognitive flexibility
  • Track 6-5Autonomic nervous system
  • Track 6-6Orthostatic hypotension
  • Track 6-7Paresthesia
  • Track 6-8Brain cell death
  • Track 6-9Neocortex
  • Track 6-10Multiple system atrophy
  • Track 6-11Motor neuron disease
  • Track 6-12Neuroleptic malignant syndrome
  • Track 6-13Palliative care
  • Track 6-14Neuroprotective treatments
  • Track 6-15Neural transplantation
  • Track 6-16Repetitive transcranial magnetic stimulation
  • Track 7-1Depression or Hypertension
  • Track 7-2Depression or Hypertension
  • Track 7-3Pre dementia
  • Track 7-4Neuropsychiatric symptom
  • Track 7-5Cholinergic hypothesis
  • Track 7-6Cerebral cortex
  • Track 7-7Cytoskeleton
  • Track 7-8Neurofibrillary tangles
  • Track 7-9Neurological examination
  • Track 7-10Immunotherapy & vaccination
  • Track 7-11Cerebrospinal fluid
  • Track 8-1Neuroplasticity
  • Track 8-2Ischemic Encephalopathy
  • Track 8-3Dysregulation in children
  • Track 8-4Flaccid Myelitis
  • Track 8-5Pseudotumor Cerebri Syndrome
  • Track 8-6Neurodevelopmental Disabilities
  • Track 8-7Neurocutaneous Syndromes
  • Track 8-8Schizencephaly
  • Track 8-9Hydranencephaly
  • Track 8-10Polymicrogyria
  • Track 8-11Polymicrogyria
  • Track 8-12Colpocephaly
  • Track 8-13Megalencephaly
  • Track 8-14Segmental overgrowth
  • Track 9-1Vertebral column
  • Track 9-2Spinal cord injury
  • Track 9-3spinal cavity
  • Track 9-4Spinal canal
  • Track 9-5Spinal anaesthesia
  • Track 9-6Spinal adjustment
  • Track 9-7Lumbar puncture
  • Track 9-8Posterior nasal spine
  • Track 9-9Anterior nasal spine
  • Track 9-10Spine of scapula
  • Track 9-11Mental spine
  • Track 9-12Ischial spine
  • Track 10-1Acquired brain injury
  • Track 10-2Encephalopathy
  • Track 10-3Encephalopathy
  • Track 10-4Micropolygyria
  • Track 10-5Basal ganglia disease
  • Track 10-6Glial scar
  • Track 10-7Primary and secondary brain injury
  • Track 10-8Pediatric acquired brain injury
  • Track 10-9Cerebellopontine angle syndrome
  • Track 10-10Right hemisphere brain damage
  • Track 10-11Medial medullary syndrome
  • Track 10-12Ventriculitis
  • Track 11-1Spinal cord neoplasms
  • Track 11-2Intracranial metastasis
  • Track 11-3Skull metastasis
  • Track 11-4Spinal metastasis
  • Track 11-5Nongenetic risk factors
  • Track 11-6Peri tumoral factors
  • Track 11-7Hypoxia, acidosis & metabolic changes
  • Track 11-8Glutamate neurotransmission
  • Track 11-9Lumbar puncture
  • Track 11-10Cerebrospinal fluid analysis
  • Track 12-1Spinal neurosurgery
  • Track 12-2Ablative surgery
  • Track 12-3Brain stimulation surgery
  • Track 12-4Spondylosis
  • Track 12-5Congenital hydrocephalus
  • Track 12-6Conventional surgery
  • Track 12-7Craniopharyngiomas
  • Track 12-8Endoscopic endonasal surgery
  • Track 12-9Novalis Radiosurgery
  • Track 12-10Peripheral nerve surgery
  • Track 12-11Radiotherapy
  • Track 12-12Skull base surgery
  • Track 12-13Epilepsy surgery
  • Track 12-14Functional neurosurgery
  • Track 12-15Vascular neurosurgery
  • Track 12-16Stereotactic surgery
  • Track 12-17Pediatric neurosurgery
  • Track 12-18Neurosurgical Interventions
  • Track 12-19Corticosteroids
  • Track 12-20Chemotherapy
  • Track 13-1Neuro chemicals
  • Track 13-2Neuro transmitters
  • Track 13-3Neuropeptides
  • Track 13-4Psychopharmaceuticals
  • Track 13-5Cortical plasticity
  • Track 13-6Neurogenesis
  • Track 13-7Norepinephrine
  • Track 13-8Putative neurotransmitters
  • Track 13-9Neuroplasticity
  • Track 14-1Neurochemical interactions
  • Track 14-2Molecular neuropharmacology
  • Track 14-3Agonist
  • Track 14-4Competitive antagonist
  • Track 14-5Neuropsychopharmacology
  • Track 14-6Dopamine
  • Track 14-7Serotonin
  • Track 14-8Behavioral neuropharmacology
  • Track 14-9Ion channels
  • Track 15-1Maladaptations
  • Track 15-2Psychotherapy
  • Track 15-3Assertive community treatment
  • Track 15-4Community reinforcement
  • Track 15-5Personality disorders
  • Track 15-6Psychiatric illnesses
  • Track 15-7Psychopathology
  • Track 15-8Humanistic psychology
  • Track 15-9Psychoanalysis
  • Track 15-10Child & Adolescent Psychiatry
  • Track 15-11Clinical neurophysiology
  • Track 16-1Patient care
  • Track 16-2Occupational stress
  • Track 16-3Mental health nursing
  • Track 16-4Adult nursing
  • Track 16-5Intravenous drug therapy
  • Track 16-6Public health
  • Track 16-7Midwifery
  • Track 16-8Nursing Assistant
  • Track 16-9Clinical nurse
  • Track 16-10Circadian rhythm sleep disorders
  • Track 17-1Sleep deprivation
  • Track 17-2Dyssomnias
  • Track 17-3Idiopathic hypersomnia
  • Track 17-4Hypersomnia
  • Track 17-5Cognitive behavioral therapy
  • Track 17-6Chronotherapy
  • Track 17-7Continuous positive airway pressure
  • Track 17-8Reversed vegetative symptoms
  • Track 18-1Stimulus control of behavior
  • Track 18-2Cognitive control of behavior
  • Track 18-3Epigenetic factors
  • Track 18-4Reward sensitization
  • Track 18-5Behavioral addiction
  • Track 18-6Addiction vulnerability
  • Track 18-7Comorbid disorders
  • Track 18-8Epigenome
  • Track 18-9Mesocorticolimbic projection
  • Track 18-10 Over expression
  • Track 18-11Nucleus accumbens
  • Track 18-12Spiny neurons
  • Track 19-1Mental illness
  • Track 19-2Depression & Anxiety
  • Track 19-3Social hygiene movement
  • Track 19-4Eugenics & sterilisation
  • Track 19-5Childhood & adolescence
  • Track 19-6Emotional issues
  • Track 19-7Neuropsychiatric disorders
  • Track 19-8Mental health service
  • Track 19-9Trepanation
  • Track 19-10Lobotomy
  • Track 19-11Exorcisms
  • Track 19-12Activity therapies
  • Track 19-13Expressive therapies
  • Track 19-14Psychotherapy
  • Track 19-15Spiritual counseling
  • Track 19-16Meditation
  • Track 20-1Homeostasis
  • Track 20-2Etiology
  • Track 20-3Neurodegenerative processes
  • Track 20-4Neuroendocrine
  • Track 20-5Neuropeptides
  • Track 20-6Neuroinflammation & Neuroimmune activation
  • Track 20-7Neurotrophins
  • Track 20-8Neurological diseases
  • Track 20-9Neuro biomarkers
  • Track 20-10Neural stem cell fate
  • Track 20-11Neurodevelopmental disorders
  • Track 20-12Neurodegenerative disorders
  • Track 20-13Neuroimmunological disorders
  • Track 20-14Neuroimmune system
  • Track 20-15Psychosomatic illness
  • Track 20-16Glial cells
  • Track 21-1Axonal regeneration
  • Track 21-2Cytokines
  • Track 21-3Innate immune cells
  • Track 21-4Neuroimmune response
  • Track 21-5Peripheral immune response
  • Track 21-6Spinal cord injury
  • Track 21-7Toxic metabolites
  • Track 21-8Traumatic brain injury
  • Track 21-9Cytokines
  • Track 21-10Neuromodulators
  • Track 21-11Neuronal cytotoxicity
  • Track 21-12Peripheral immune response
  • Track 21-13Aging
  • Track 21-14Cognitive impairment
  • Track 21-15Cognitive impairment
  • Track 22-1Mild brain injuries
  • Track 22-2Moderate brain injuries
  • Track 22-3Brain damage predicts symptoms
  • Track 22-4Neurocognitive deficits
  • Track 22-5Parietal lobes
  • Track 22-6Fusiform gyrus
  • Track 22-7Amorphosynthesis
  • Track 22-8Post traumatic amnesia
  • Track 22-9Apraxia
  • Track 22-10Open head injury
  • Track 22-11Closed head injury
  • Track 22-12Diffuse axonal
  • Track 22-13Occupational therapists
  • Track 23-1Interdisciplinary nature
  • Track 23-2Artificial intelligence
  • Track 23-3Electroencephalography
  • Track 23-4Functional magnetic resonance imaging
  • Track 23-5Optical imaging
  • Track 23-6Magnetoencephalography
  • Track 23-7Computational modeling
  • Track 23-8Embodied cognition
  • Track 23-9Educational neuroscience
  • Track 23-10Heterophenomenology
  • Track 23-11Epistemology
  • Track 23-12Enactivism
  • Track 23-13Catalepsy
  • Track 24-1Gene sequencing
  • Track 24-2Nuclear magnetic resonance imaging
  • Track 24-3Aggression
  • Track 24-4Neural development
  • Track 24-5Neurogenesis
  • Track 24-6Neural tube
  • Track 24-7Sensory neurons
  • Track 24-8Behavioral genetics
  • Track 24-9ventral ectoderm
  • Track 25-1Infections
  • Track 25-2Addiction
  • Track 25-3Arachnoid cysts
  • Track 25-4Attention deficit/hyperactivity disorder (ADHD)
  • Track 25-5Autism
  • Track 25-6Autoimmune disorders
  • Track 25-7Bipolar disorder
  • Track 25-8Degeneration
  • Track 25-9Depression
  • Track 25-10Encephalitis
  • Track 25-11Epilepsy/Seizures
  • Track 25-12Tumors
  • Track 25-13Locked-in syndrome
  • Track 25-14Meningitis
  • Track 25-15Migraine
  • Track 25-16Multiple sclerosis
  • Track 25-17Myelopathy
  • Track 25-18Neurodegenerative disorders
  • Track 25-19Stroke
  • Track 25-20Structural defects
  • Track 25-21Trauma
  • Track 26-1Genetic disorder
  • Track 26-2Prenatal screening
  • Track 26-3Chromosome abnormalities
  • Track 26-4Mental impairment
  • Track 26-5Low muscle tone
  • Track 26-6Flexible ligaments
  • Track 26-7Flat head
  • Track 26-8Intellectual disability
  • Track 26-9Mosaic Down syndrome
  • Track 26-10Infantile spasms
  • Track 26-11Sensorineural type
  • Track 26-12Transient myeloproliferative disease
  • Track 26-13Tumor suppressor genes
  • Track 26-14Autoimmune hypothyroidism
  • Track 26-15Epigenetics
  • Track 27-1Aversion therapy
  • Track 27-2Retail therapy
  • Track 27-3Cognitive behavioral therapy
  • Track 27-4Opioid
  • Track 27-5Drug rehabilitation
  • Track 27-6Drug addiction treatment
  • Track 27-7Chemical addiction in brain disease
  • Track 27-8Clinical case management
  • Track 27-9Detoxification
  • Track 27-10Individual Therapy
  • Track 27-11Pharmacological Therapy
  • Track 27-12Health & Medical Services
  • Track 28-1Holistic
  • Track 28-2Inclusive Care plans
  • Track 28-3Occupational therapy
  • Track 28-4Psychological therapy
  • Track 28-5language therapy
  • Track 28-6Vision therapy
  • Track 28-7Neurophysiotherapy
  • Track 29-1Positron emission tomography
  • Track 29-2Magnetoencephalography
  • Track 29-3Magnetoencephalography
  • Track 29-4Magnetic resonance imaging
  • Track 29-5Functional Magnetic Resonance Imaging
  • Track 29-6Functional magnetic resonance imaging
  • Track 29-7Event-related optical signal
  • Track 29-8Diffuse optical imaging
  • Track 29-9Cranial ultrasound
  • Track 29-10Computed Tomography
  • Track 29-11Computed axial tomography
  • Track 29-12Brain imaging techniques
  • Track 29-13Advantages and Concerns of Neuroimaging Techniques
  • Track 29-14Electroencephalography
  • Track 30-1Musculoskeletal disorders
  • Track 30-2Human musculoskeletal system
  • Track 30-3Carpal tunnel syndrome
  • Track 30-4Epicondylitis
  • Track 30-5Tendinitis
  • Track 30-6Carpal tunnel syndrome
  • Track 30-7Ergonomics
  • Track 31-1Clinical psychology
  • Track 31-2Child Psychology
  • Track 31-3Cognitive psychology
  • Track 31-4Psychological Disorders
  • Track 31-5Neuropsychology
  • Track 31-6Abnormal Psychology